Literature DB >> 3322954

Absence of complement fixing antibodies against lipopolysaccharides from Escherichia coli in a subgroup of patients with Crohn's disease.

M Zeitz1, U Hope, B Wust, C Galanos, B Möller, T J Lawley, E O Riecken.   

Abstract

Complement fixing antibodies against different Escherichia coli lipopolysaccharides were determined in patients with Crohn's disease and in healthy individuals and compared with antitetanus toxoid antibodies. All healthy individuals had antilipopolysaccharide antibodies, 10 of 27 patients with Crohn's disease had no antibodies and six had rapidly changing antibody titres. These abnormalities were found in patients with disease in the colon, with arthropathy and fistula. Antilipid A was found at lower titres in Crohn's disease. Neither antitetanus toxoid antibodies, nor immunoglobulin concentrations were different in patients with or without antilipopolysaccharide antibodies. There was no evidence for circulating immune complexes in patients lacking antilipopolysaccharide antibodies. Certain subgroups of patients with Crohn's disease have altered antibody levels to typical enteral antigens which most likely can be explained by local antibody binding to lipopolysaccharides at inflammatory sites, or by changes in immunoregulation in this disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322954      PMCID: PMC1433671          DOI: 10.1136/gut.28.11.1460

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  18 in total

1.  Escherichia coli antibodies in patients with inflammatory bowel disease.

Authors:  S Tabaqchali; D P O'Donoghue; K A Bettelheim
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

2.  Demonstration of circulating immune complexes in Sjögren's syndrome.

Authors:  T J Lawley; H M Moutsopoulos; S I Katz; A N Theofilopoulos; T M Chused; M M Frank
Journal:  J Immunol       Date:  1979-09       Impact factor: 5.422

3.  Abnormalities of B-cell activation and immunoregulation in patients with Crohn's disease.

Authors:  G Sieber; F Herrmann; M Zeitz; H Teichmann; H Rühl
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

4.  The induction and suppression of in vitro IgG anti-tetanus toxoid antibody synthesis by human lymphocytes stimulated with tetanus toxoid in the absence of in vivo booster immunizations.

Authors:  L G Lum; N J Culbertson
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

5.  Patients with active Crohn's disease have elevated serum antibodies to antigens of seven enteric bacterial pathogens.

Authors:  M J Blaser; R A Miller; J Lacher; J W Singleton
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

6.  Studies on isolated gut mucosal lymphocytes in inflammatory bowel disease. Detection of activated T cells and enhanced proliferation to Staphylococcus aureus and lipopolysaccharides.

Authors:  C Fiocchi; J R Battisto; R G Farmer
Journal:  Dig Dis Sci       Date:  1981-08       Impact factor: 3.199

7.  Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease.

Authors:  W Kruis; P Schussler; M Weinzierl; C Galanos; J Eisenburg
Journal:  Dig Dis Sci       Date:  1984-06       Impact factor: 3.199

8.  Suppression of immunoglobulin synthesis by lymphocyte subpopulations in patients with Crohn's disease.

Authors:  S P James; L M Neckers; A S Graeff; J Cossman; C M Balch; W Strober
Journal:  Gastroenterology       Date:  1984-06       Impact factor: 22.682

9.  Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn's disease and ulcerative colitis patients.

Authors:  R Stevens; M Oliver; M Brogan; J Heiserodt; S Targan
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

10.  Limitations of immune complex measurements in colorectal disease.

Authors:  J Hobbiss; K M Cooper; M Moore; E Gowland; P F Schofield
Journal:  Br J Surg       Date:  1983-08       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.